ClinicalTrials.Veeva

Menu

Sodium Creatine Phosphate in Heart Valve Surgery

C

Chinese Academy of Medical Sciences, Fuwai Hospital

Status

Unknown

Conditions

Heart Valve Diseases

Treatments

Drug: sodium creatine phosphate
Drug: saline

Study type

Interventional

Funder types

Other

Identifiers

NCT03186053
FWT2017-ZX004

Details and patient eligibility

About

To explore the effect of intraoperative sodium creatine phosphate on myocardial protection in patients undergoing valve surgery

Full description

Objective: To explore the effect of intraoperative sodium creatine phosphate on myocardial protection in patients undergoing valve surgery Methods: 250 patients undergoing valve surgery were randomly divided into experimental group and control group. 5g creatine phosphate was dissolved in 50ml saline solution. After induction of anesthesia, the patients were first given a load dose of 1g, 20min (30ml / h) , And then pumped at a rate of 1 g / h (10 ml / h). The control group was treated with saline in the same manner. The cTnI level was measured at the corresponding time points. Hemodynamic indexes and postoperative complications were recorded.

Enrollment

250 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • valvular disease patients requiring valvular replacement or repair surgery with cardiopulmonary bypass(CPB)

Exclusion criteria

  • thoracoscopic valve surgery
  • other organ dysfunction: such as cancer, organ failure, severe anemia, infection
  • patients with mental disorders
  • coagulopathy, active ulcer, ischemic or hemorrhagic stroke (within 6 months), trauma

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

250 participants in 2 patient groups, including a placebo group

sodium creatine phosphate
Experimental group
Description:
5g creatine phosphate was dissolved in 50ml saline solution. After induction of anesthesia, the patients were first given a load dose of 1g, 20min (30ml / h) , And then pumped at a rate of 1 g / h (10 ml / h).
Treatment:
Drug: sodium creatine phosphate
Control
Placebo Comparator group
Description:
The control group was treated with saline in the same manner.
Treatment:
Drug: saline

Trial contacts and locations

2

Loading...

Central trial contact

Zhongrong FANG, M.D; Guyan WANG, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems